250 likes | 1.06k Views
Medical Nutrition Therapy for Nephrolithiasis. Tara J. Ray Concordia College Moorhead, MN. Objectives . Describe the condition of Nephrolithiasis Determine how to assess a patient with Nephrolithiasis Identify risk factors contributing to development of Nephrolithiasis
E N D
Medical Nutrition Therapy for Nephrolithiasis Tara J. Ray Concordia College Moorhead, MN
Objectives • Describe the condition of Nephrolithiasis • Determine how to assess a patient with Nephrolithiasis • Identify risk factors contributing to development of Nephrolithiasis • Understand medical nutrition therapy for Nephrolithiasis
Definition • What is Nephrolithiasis? • Also known as “Kidney Stones” • Kidney Stones are solid crystalline masses formed in the kidney that must pass through the urinary tract Nelms, Marcia, Sucher, Kathryn & Long, Sara. (2007). Nutrition Therapy and Pathophysiology. Belmont: Thomson.
Prevalence • Nephrolithiasis affects over 5% of adults in the United States • 12% men • 6% women • 50% of patients will have additional stones Asplin, John R. (2008). Evaluation of a Kidney Stone Patient. Seminars in Nephrology, 28, 99-110. Worcester, Elaine M. & Coe, Fredric L. (2008). Nephrolithiasis. Prim Care; 35(2), 369–vii. Retrieved September 9, 2009, from Pub Med database.
Signs and Symptoms • Hematuria • Nausea and vomiting • Pain with urination • Urgency to urinate • Lower flank pain Nelms, Marcia, Sucher, Kathryn & Long, Sara. (2007). Nutrition Therapy and Pathophysiology. Belmont: Thomson.
Assessment and Analysis • GOLD STANDARD for detection of stones • Computerized Tomography (CT) scan • If stone is captured • Crystallographic analysis techniques • Type of stone is determined • Assess dietary habits • Quantify number of stones and duration of stone disease • Single Stone • Serum electrolytes, creatinine , calcium • Multiple/Recurring Stones • 24-hour urine screening Asplin, John R. (2008). Evaluation of a Kidney Stone Patient. Seminars in Nephrology, 28, 99-110.
Types of Stones • Calcium Oxalate (CaOx) • Uric Acid (UA) • Magnesium Ammonium Phosphate • Calcium Phosphate • Struvite • Cystine • Carbon Apatite Worcester, Elaine M., Parks, Joan H., Evan, Andrew P. & Coe, Fredric L. (2006). Renal Function in Patients with Nephrolithiasis. Journal of Urology, 176, 600-603.
Pathophysiology • Urine calcium concentration determines level of supersaturation • Both high and low levels of calcium can be a risk • Supersaturation can predict type of stone • Hypercalciuria – most common metabolic abnormality • > 300 mg/day men • > 250 mg/day women • Hyperoxaluria – 30% Nephrolithaisis patients • > 90 mg/day • Hypocitrauria • < 325 mg/day Asplin, John R. (2008). Evaluation of a Kidney Stone Patient. Seminars in Nephrology, 28, 99-110. Worcester, Elaine M. & Coe, Fredric L. (2008). Nephrolithiasis. Prim Care; 35(2), 369–vii. Retrieved September 9, 2009, from Pub Med database.
Pathophysiology • Hyperuricosuria – 10-25% Nephrolithaisis patients • Urine pH • Increased urine pH (more basic) leads to calcium phosphate stones • Decreased urine pH (more acidic) leads to uric acid stones • Volume • High fluid intake reduces stone reoccurrence • Electrolytes • Magnesium Asplin, John R. (2008). Evaluation of a Kidney Stone Patient. Seminars in Nephrology, 28, 99-110.
Risk Factors • Increased BMI • Increased waist circumference • Genetics • Hypertension • Hypercalciuria • Vitamin C • Diarrheal state Asplin, John R. (2008). Evaluation of a Kidney Stone Patient. Seminars in Nephrology, 28, 99-110. Moe, Orson W., Abate, Nicola & Sakhaee, Khashayar. (2002). Pathophysiology of uric acid nephrolithiasis. Endocrinol Metab Clin N Am, 31, 895-914. Worcester, Elaine M. & Coe, Fredric L. (2008). Nephrolithiasis. Prim Care; 35(2), 369–vii. Retrieved September 9, 2009, from Pub Med database. Worcester, Elaine M., Parks, Joan H., Evan, Andrew P. & Coe, Fredric L. (2006). Renal Function in Patients with Nephrolithiasis. Journal of Urology, 176, 600-603.
Risk Factors • Urinary Tract Infection • Catheterization • Bowel Disease • Environmental Factors: • Heat exposure • Employment • Exercise Asplin, John R. (2008). Evaluation of a Kidney Stone Patient. Seminars in Nephrology, 28, 99-110. Moe, Orson W., Abate, Nicola & Sakhaee, Khashayar. (2002). Pathophysiology of uric acid nephrolithiasis. Endocrinol Metab Clin N Am, 31, 895-914.
Research Studies • Retrospective, prospective, epidemiologic and population based studies all concluded Nephrolithiasis corresponds with body mass and diabetes based on increased incidence in all cases • DKD – Diabetic Kidney Disease • American Dietetic Association Evidenced Based Library • Randomized control study trail with diabetic subjects • Nurse’s Health Study • Healthy portions of protein from: fish, poultry, soy, dairy Moe, Orson W., Abate, Nicola & Sakhaee, Khashayar. (2002). Pathophysiology of uric acid nephrolithiasis. Endocrinol Metab Clin N Am, 31, 895-914.
Research Studies • Population based study in Olmsted, MN • Tested hypothesis that diabetes mellitus prevalence is increased in people who develop renal stones • Those diagnosed with Nephrolithiasis tended to have high BMI and show signs of hypertension • Uric Acid stone were shown to be most common • Results: • Calcium Oxalate stones in 93 persons 76% • Calcium Phosphate stones in 19 persons 16% • Uric Acid stones in 10 persons 8% Lieske, John C., Pena de ka Vega, Lourdes S., Gettman, Matthew T., Slezak, Jeffrey M., Bergstralh, Eric J., Melton, L. Joseph & Leibson, Cynthia L. (2006). Diabetes Mellitus and the Risk of Urinary Tract Stones: A Population-Based Case-Control Study, American Journal of Kidney Disease. 48, 897-904.
Research Studies • The American Journal of Hypertension • Positive association of hypertension and Nephrolithiasis • 60 men with confirmed cases of Nephrolithiasis • 77 men with confirmed cases of hypertension and risk of stroke • Cross sectional analysis • Men with history of Nephrolithiasis were 29% more likely to report cases of hypertension • Men with hypertension were not likely to develop Nephrolithiasis Madore, Francois, Stampfer, Meir J., Rimm, & Eric B., Curham, Gary C. (1998). Nephrolithiasis and Risk of Hypertension. American Journal of Hypertension, 11, 46-53.
Medical Nutrition Therapy • The goal of MNT for Nephrolithiasis is to prevent new stone formation and prevent preexisting stones from growing Asplin, John R. (2008). Evaluation of a Kidney Stone Patient. Seminars in Nephrology, 28, 99-110. Worcester, Elaine M., Parks, Joan H., Evan, Andrew P. & Coe, Fredric L. (2006). Renal Function in Patients with Nephrolithiasis. Journal of Urology, 176, 600-603.
Medical Nutrition Therapy • Diet used as preventative therapy should be considered • Restriction of calories is relatively safe • Inexpensive compared to medication • Improved glucose tolerance and cardiovascular benefits • Weight Watchers • Reduce calorie intake • Well rounded menu with an infrastructure that makes it appealing to many • DASH Diet • Encourages fruits, whole grain, vegetables, low fat dairy, poultry, fish, nuts • Limited fats, red meats, sodium Goldfarb, David S. (2009). Prospects for Dietary Therapy of Recurrent Nephrolithiasis. Advances in Chronic Kidney Disease, 16, 21-29.
Medical Nutrition Therapy • Decrease sodium to 100 mmol/day • To prevent Calcium containing stones • Decrease excessive animal protein • To prevent Uric acid and calcium stones • > 1 g/kg should be avoided • Recommendation 1 g/kg • .6 g/kg for diabetic patients Avoid grapefruit juice, beets, cola, chocolate, coffee, tea, berries, spinach, and rhubarb Asplin, John R. (2008). Evaluation of a Kidney Stone Patient. Seminars in Nephrology, 28, 99-110. Nelms, Marcia, Sucher, Kathryn & Long, Sara. (2007). Nutrition Therapy and Pathophysiology. Belmont: Thomson. Vergili, Joyce M. (2009). Diabetic Kidney Diesase: What RDs need to know. Today’s Dietitian, 11, 8-48. Worcester, Elaine M. & Coe, Fredric L. (2008). Nephrolithiasis. Prim Care; 35(2), 369–vii. Retrieved September 9, 2009, from Pub Med database.
Medical Nutrition Therapy • Increase calcium intake to 1000 -1200 mg/day *** • Increase fluids with at least 50% WATER • 2.5-3 L/day • Urine volume should be 2 L/day • < 50 mg/day dietary oxalate • To prevent Calcium Oxalate stones • Increase fruits and vegetables • Increase insoluble fiber • Weight loss • Low fat, low calorie Asplin, John R. (2008). Evaluation of a Kidney Stone Patient. Seminars in Nephrology, 28, 99-110. Goldfarb, David S. (2009). Prospects for Dietary Therapy of Recurrent Nephrolithiasis. Advances in Chronic Kidney Disease, 16, 21-29.
Medications • Thiazides • Relatively easy alternative to diet, more simple to comply with • Chlorthialidone • Hydrochlorothiazide • Indapamide • Vitamins and supplements • Avoid calcium supplements • Pharmaceutical companies develop oral preparations to degrade oxalate in the intestinal lumen • Altu-237 • Oxazyme Asplin, John R. (2008). Evaluation of a Kidney Stone Patient. Seminars in Nephrology, 28, 99-110. Goldfarb, David S. (2009). Prospects for Dietary Therapy of Recurrent Nephrolithiasis. Advances in Chronic Kidney Disease, 16, 21-29. Worcester, Elaine M. & Coe, Fredric L. (2008). Nephrolithiasis. Prim Care; 35(2), 369–vii. Retrieved September 9, 2009, from Pub Med database.
Ethics • Children • Pharmaceutical testing Goldfarb, David S. (2009). Prospects for Dietary Therapy of Recurrent Nephrolithiasis. Advances in Chronic Kidney Disease, 16, 21-29. Worcester, Elaine M. & Coe, Fredric L. (2008). Nephrolithiasis. Prim Care; 35(2), 369–vii. Retrieved September 9, 2009, from Pub Med database.
Conclusion • Nephrolithiasis is the condition of crystals forming in the urinary tract from buildup of waste products in the bloodstream filtered by the kidneys • Determining the type of stone is crucial for dietary treatment • Drinking water is the most important thing a person can do to prevent kidney stones